Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis

This study aimed to directly analyze the potential relationship of anti-nuclear antibodies (ANA) before and after the administration of TNF-α inhibitors (TNFi) with the appearance of anti-drug antibodies (ADrA) in patients with rheumatoid arthritis (RA). A total of 121 cases, viz., 38, 53, and 30 ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Ayano, Saito, Toshiharu, Takahashi, Miho, Shibata, Miho, Tsuji, Goh, Hatachi, Saori, Takahashi, Soshi, Kumagai, Shunichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735569/
https://www.ncbi.nlm.nih.gov/pubmed/33315881
http://dx.doi.org/10.1371/journal.pone.0243729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735569/
https://www.ncbi.nlm.nih.gov/pubmed/33315881
http://dx.doi.org/10.1371/journal.pone.0243729

Ejemplares similares